{
  "id": 2390970,
  "title": "Shareholder pressures Capricor; Lilly dives deeper into vaccines",
  "url": "https://urgent.news/2026/08/21/shareholder-pressures-capricor-lilly-dives-deeper-into-vaccines",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-21T13:30:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/capricor-kaos-bristol-myers-chai-lilly-amplitude-kynexis/828284/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Kaos Capital wants a “governance reset” to alter the Duchenne cell therapy maker’s strategic course. Elsewhere, Bristol Myers furthered efforts to build an “AI-powered” discovery engine.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}